Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

13.94
Delayed Data
As of Apr 28
 -0.05 / -0.36%
Today’s Change
7.70
Today|||52-Week Range
15.20
+41.09%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close13.99
Today’s open14.03
Day’s range13.69 - 14.04
Volume624,851
Average volume (3 months)1,664,375
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-224.00%
Earnings growth (this year)-19.54%
Earnings growth (next 5 years)+15.41%
Revenue growth (last year)+8.61%
P/E ratioNM
Price/Sales8.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...+0.13+0.22%
BPMCBlueprint Medicines ...+0.58+1.26%
RDUSRadius Health Inc+0.35+0.90%
AVXSAveXis Inc+1.74+2.21%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$146.7M
Annual profit (last year)-$103.0M
Net profit margin-70.23%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts